Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
03.10.25
/
50%
€134.00
Target price
03.10.26
€167.19
Performance (%)
13.43%
Price
09.01.26
€146.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 13.43%. This prediction currently runs until 03.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.311% | -3.311% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $121.00 to $196.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat